Syndax Pharmaceuticals Inc (SNDX)
20.57
-0.22
(-1.06%)
USD |
NASDAQ |
Apr 25, 16:00
20.58
+0.01
(+0.05%)
After-Hours: 20:00
Syndax Pharmaceuticals Market Cap: 1.749B for April 25, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 24, 2024 | 1.767B |
| April 23, 2024 | 1.782B |
| April 22, 2024 | 1.781B |
| April 19, 2024 | 1.768B |
| April 18, 2024 | 1.741B |
| April 17, 2024 | 1.762B |
| April 16, 2024 | 1.808B |
| April 15, 2024 | 1.837B |
| April 12, 2024 | 1.846B |
| April 11, 2024 | 1.897B |
| April 10, 2024 | 1.870B |
| April 09, 2024 | 1.955B |
| April 08, 2024 | 1.938B |
| April 05, 2024 | 1.945B |
| April 04, 2024 | 1.922B |
| April 03, 2024 | 2.022B |
| April 02, 2024 | 1.979B |
| April 01, 2024 | 2.021B |
| March 28, 2024 | 2.023B |
| March 27, 2024 | 1.960B |
| March 26, 2024 | 1.822B |
| March 25, 2024 | 1.907B |
| March 22, 2024 | 1.919B |
| March 21, 2024 | 1.944B |
| March 20, 2024 | 1.957B |
| Date | Value |
|---|---|
| March 19, 2024 | 1.888B |
| March 18, 2024 | 1.863B |
| March 15, 2024 | 1.999B |
| March 14, 2024 | 1.925B |
| March 13, 2024 | 2.019B |
| March 12, 2024 | 2.028B |
| March 11, 2024 | 2.003B |
| March 08, 2024 | 2.088B |
| March 07, 2024 | 1.994B |
| March 06, 2024 | 2.018B |
| March 05, 2024 | 1.949B |
| March 04, 2024 | 1.980B |
| March 01, 2024 | 2.015B |
| February 29, 2024 | 1.992B |
| February 28, 2024 | 2.029B |
| February 27, 2024 | 2.074B |
| February 26, 2024 | 2.071B |
| February 23, 2024 | 1.965B |
| February 22, 2024 | 1.930B |
| February 21, 2024 | 1.889B |
| February 20, 2024 | 1.943B |
| February 16, 2024 | 1.906B |
| February 15, 2024 | 1.923B |
| February 14, 2024 | 1.865B |
| February 13, 2024 | 1.800B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
147.37M
Minimum
Oct 09 2019
2.088B
Maximum
Mar 08 2024
952.44M
Average
923.92M
Median
Sep 14 2021
Market Cap Benchmarks
| SpringWorks Therapeutics Inc | 3.261B |
| Alnylam Pharmaceuticals Inc | 18.10B |
| Geron Corp | 1.949B |
| Ionis Pharmaceuticals Inc | 6.095B |
| Madrigal Pharmaceuticals Inc | 3.867B |
Market Cap Related Metrics
| PS Ratio | 10.37 |
| Price to Book Value | 3.156 |
| Price | 20.57 |
| Earnings Yield | -14.38% |
| Operating PE Ratio | 55.23 |
| Normalized PE Ratio | 47.86 |